Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-054828
Filing Date
2021-09-03
Accepted
2021-09-03 17:23:19
Documents
1
Period of Report
2021-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6007
  Complete submission text file 0001209191-21-054828.txt   7530
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. ONE FIRST AVENUE, PARRIS BLDG 34 BOSTON MA 02129
Business Address
Weis Holger (Reporting) CIK: 0001846984 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 211237518